AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Asparaginase (Systemic).

USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language

| July 28, 2005 | COPYRIGHT 1996 USP DIĀ® and Advice for the PatientĀ® are registered trademarks of USP used under license to Micromedex, Inc. (Hide copyright information)Copyright
 
In the U.S. -- 
     Elspar 
 
In Canada -- 
     Kidrolase 

Another commonly used name is colaspase .

 
     Antineoplastic 
Description 

Asparaginase ( a-SPARE-a-gi-nase) belongs to the group of medicines known as enzymes. It is used to treat some kinds of cancer of the blood. It may also be used to treat other kinds of cancer, as determined by your doctor.

All cells need a chemical called asparagine to stay alive. Normal cells can make this chemical for themselves, while cancer cells cannot. Asparaginase breaks down asparagine in the body. Since the cancer cells cannot make more asparagine, they die.

Before you begin treatment with asparaginase, you and your doctor should talk about the good this medicine will do as well as the risks of using it.

Asparaginase is to be administered only by or under the supervision of your doctor. It is available in the following dosage form:

 
Parenteral 
 
     Injection (U.S. and Canada) 
Before Using This Medicine 

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For asparaginase, the following should be considered:

 
Allergies -- 

Tell your doctor if you have ever had any unusual or allergic reaction to asparaginase.

 
Pregnancy -- 

Asparaginase has not been studied in pregnant women. However, studies in mice and rats have shown that asparaginase slows the weight gain of infants and may also …

Related articles from newspapers, magazines, journals, and more
Asparaginase (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language October 27, 2005 700+ words
Asparaginase (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2006 700+ words
ASPARAGINASE (Injection route) - a-SPARE-a-ji-nase.(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2007 700+ words
European Medicines Agency decision P/209/2010 of 29 Oct 2010 on the agreement...
News wire article from: Chemical Business Newsbase November 25, 2010 700+ words
European Medicines Agency decision of 27 Jan 2009 on the acceptance of a...
News wire article from: Chemical Business Newsbase March 6, 2009 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily